Learn more about our Payment & Health Care Delivery Policy work.
Lishan Aklog, MD, Chairman and CEO of PAVmed and Lucid Diagnostic, joined AdvaMed’s Scott Whitaker on the Medtech POV podcast to discuss how the reimbursement system works for medtech companies and the…
AdvaMed released the following statement from President and CEO Scott Whitaker on the Administration’s announcement today that, (1) beginning in January, private insurance plans will cover the cost of at-home…
Today, the Advanced Medical Technology Association (AdvaMed) released the following statement from President and CEO Scott Whitaker regarding the Centers for Medicare and Medicaid Services (CMS) recission of the Medicare…
Medical devices can offer important therapeutic advances but, as for any medical interventions, there are questions about their costs and benefits.
AdvaMed released the following statement from President and CEO Scott Whitaker regarding the final Physician Fee Schedule rule released yesterday by the Centers for Medicare and Medicaid Services (CMS):
Today, the Advanced Medical Technology Association (AdvaMed) submitted comments to the Centers for Medicare & Medicaid Services (CMS) on its proposal to repeal the Medicare Coverage of Innovative Technology (MCIT)…
Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today that the Centers for Medicare & Medicaid…
Rhaeos, Inc., a private medical device company focused on the care of patients with hydrocephalus, announced today it was awarded a $4 million, multi-year grant from the National Institutes of…
Vibrato Medical, an innovator in the treatment of peripheral arterial disease (PAD), announced today that it has closed a $4M Series A funding round led by the Horowitz Group, a…
In the most recent episode of the Medtech POV Podcast, a top medtech venture capital investor argued that if a medical device has received FDA approval as safe and effective…